Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
68,143,293
-
Share change
-
+1,928,765
-
Total reported value
-
$1,562,080,292
-
Put/Call ratio
-
22%
-
Price per share
-
$22.92
-
Number of holders
-
143
-
Value change
-
+$58,456,223
-
Number of buys
-
86
-
Number of sells
-
51
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q3 2023
As of 30 Sep 2023,
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) was held by
143 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,143,293 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, NEA Management Company, LLC, Polar Capital Holdings Plc, Frazier Life Sciences Management, L.P., and STATE STREET CORP.
This page lists
143
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.